JP2018528441A5 - - Google Patents

Download PDF

Info

Publication number
JP2018528441A5
JP2018528441A5 JP2018533586A JP2018533586A JP2018528441A5 JP 2018528441 A5 JP2018528441 A5 JP 2018528441A5 JP 2018533586 A JP2018533586 A JP 2018533586A JP 2018533586 A JP2018533586 A JP 2018533586A JP 2018528441 A5 JP2018528441 A5 JP 2018528441A5
Authority
JP
Japan
Prior art keywords
capture reagent
biomarker
aptamers
antibodies
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018533586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528441A (ja
JP6857185B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2015/009552 external-priority patent/WO2017043679A1/en
Publication of JP2018528441A publication Critical patent/JP2018528441A/ja
Publication of JP2018528441A5 publication Critical patent/JP2018528441A5/ja
Application granted granted Critical
Publication of JP6857185B2 publication Critical patent/JP6857185B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018533586A 2015-09-11 2015-09-11 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法 Active JP6857185B2 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2015/009552 WO2017043679A1 (en) 2015-09-11 2015-09-11 Protein biomarker panel for detecting non-small cell lung cancer and method for diagnosing a non-small cell lung cancer by the use thereof

Publications (3)

Publication Number Publication Date
JP2018528441A JP2018528441A (ja) 2018-09-27
JP2018528441A5 true JP2018528441A5 (enExample) 2021-03-25
JP6857185B2 JP6857185B2 (ja) 2021-04-14

Family

ID=58239995

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018533586A Active JP6857185B2 (ja) 2015-09-11 2015-09-11 非小細胞肺癌診断用タンパク質バイオマーカーパネル及びこれを用いた非小細胞肺癌診断方法

Country Status (4)

Country Link
JP (1) JP6857185B2 (enExample)
KR (2) KR102087373B1 (enExample)
CN (1) CN108026584B (enExample)
WO (1) WO2017043679A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7548903B2 (ja) * 2018-11-20 2024-09-10 ヴェンタナ メディカル システムズ， インク． 形態学的特徴およびバイオマーカー発現のために細胞サンプルを調製および分析するための方法およびシステム
TWI758670B (zh) * 2018-12-24 2022-03-21 奎克生技光電股份有限公司 健康風險評估方法
CN110333341A (zh) * 2019-07-04 2019-10-15 浙江理工大学 一种基于蛋白质芯片技术鉴别丝织品文物样的方法
WO2021151077A1 (en) 2020-01-24 2021-07-29 The Regents Of The University Of California Biomarker prediction using optical coherence tomography
MX2024008021A (es) * 2021-12-30 2024-09-06 Somalogic Operating Co Inc Secuenciacion de ultima generacion para la medicion de proteinas.
US20260100267A1 (en) * 2023-02-14 2026-04-09 The Regents Of The University Of California Systems and Methods for Automated Diagnosis of Disease Related Risk Factors in 3D Biomedical Imaging
WO2025166038A1 (en) * 2024-02-02 2025-08-07 Illumina, Inc. Improved aptamer detection techniques
CN119064600B (zh) * 2024-11-04 2025-01-24 中国科学院生物物理研究所 用于非小细胞肺癌诊断的细胞外囊泡生物标志物及其应用
CN119595908B (zh) * 2024-12-13 2025-10-17 四川大学华西医院 金属离子介导的dna功能纳米机器开关用于双标志物同时检测的分析方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3910536B2 (ja) * 2000-12-28 2007-04-25 塩野義製薬株式会社 新規ポリペプチドおよびそのｄｎａ
US7888051B2 (en) * 2007-09-11 2011-02-15 Cancer Prevention And Cure, Ltd. Method of identifying biomarkers in human serum indicative of pathologies of human lung tissues
ES2936256T3 (es) * 2008-02-01 2023-03-15 Massachusetts Gen Hospital Uso de microvesículas en el diagnóstico, y pronóstico de enfermedades y afecciones médicas
CN104198709A (zh) * 2008-09-09 2014-12-10 私募蛋白质体公司 肺癌生物标记及其用途
CA3024643C (en) * 2009-03-12 2021-08-03 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
SG168431A1 (en) * 2009-07-23 2011-02-28 Univ Singapore Cancer biomarker and the use thereof
WO2011015602A2 (en) * 2009-08-04 2011-02-10 Biosystems International Sas Lung cancer biomarkers
US9128101B2 (en) * 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
MX2012014268A (es) * 2010-07-09 2013-02-12 Somalogic Inc Biomarcadores de cancer de pulmon y usos de los mismos.
KR20140072014A (ko) * 2011-06-16 2014-06-12 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
KR20140067001A (ko) * 2011-08-08 2014-06-03 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
WO2013033019A1 (en) * 2011-08-31 2013-03-07 University Of Utah Research Foundation Methods for determining the integrity of a biological sample
BR112014000882A2 (pt) * 2011-10-24 2017-04-18 Hewlett Packard Development Co Lp dispositivo para ejeção de fluido
IN2014CN01787A (enExample) * 2011-10-24 2015-05-29 Somalogic Inc
WO2013152989A2 (en) * 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer

Similar Documents

Publication Publication Date Title
GB201816522D0 (en) Methods and reagents for analysing nucleic acids from single cells
MY170164A (en) Aptamer-based multiplexed assays
BR112018002173B8 (pt) Sistemas e métodos utilizando sensores de resposta magnética para determinar uma característica genética
WO2017055487A3 (en) A METHOD FOR DIAGNOSING A DISEASE BY DETECTION OF circRNA IN BODILY FLUIDS
JP2014132019A5 (enExample)
WO2015067969A3 (en) Method, array and use thereof for determining pancreatic cancer
WO2015095355A3 (en) Detection of an antibody against a pathogen
EP4365602A3 (en) Stomach cancer biomarker and detection method
EP4080213A4 (en) ELECTROCHEMICAL LATERAL FLOW IMMUNOLOGICAL ASSAY METHOD, CORRESPONDING SENSOR AND CORRESPONDING MANUFACTURING METHOD
IT201600073964A1 (it) Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti
MX2020003523A (es) Deteccion de dimetilarginina simetrica.
EP3216852A4 (en) Method for introducing nucleic acid, method for detecting nucleic acid, method for analyzing biological component, array device for biological component assay, and kit for analyzing biological component
EP3545314A4 (en) REAGENTS AND METHODS OF ANALYSIS OF PROTEINS AND METABOLITES TARGETED BY COVALENT PROBES
HUE048752T2 (hu) Mintabefogadó elem, analizálókészlet és eljárás egy folyadék, különösen egy hûtõ-kenõanyag emulzió elemzésére
BR112014026440A2 (pt) assays, methods and apparatus for assessing rna disruption
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
WO2015054700A3 (en) Biomarkers for predicting risk of acute ischemic stroke and methods of use thereof
JP2011518338A5 (enExample)
WO2015068075A3 (en) Detection of tau
DK3668999T5 (da) Methods and kits for detection of nucleic acid molecules
WO2015164635A3 (en) Methods and compositions for detecting anti-drug antibodies
WO2015038987A3 (en) System and method for whole-animal high-throughput compound screening
WO2014207312A3 (en) Method of predicting risk for type 1 diabetes before seroconversion
EP3371604C0 (en) ASSAY TO DETECT AND QUANTIFY SPECIFIC ANTIBODIES OF DIFFERENT REDOX FORMS OF HMGB1
EP2998408A4 (en) Method for obtaining epigenetic cell information, method for determining cell characteristics, method for assessing drug sensitivity or selecting drug or immunotherapeutic agent variety, disease diagnosis method, self-replicating vector, assay kit, and analysis device